The hyperlipidemia accompanying infection has been attributed to production of tumor necrosis factor. This cytokine inhibits adipose tissue lipoprotein lipase, which could decrease clearance of lipoproteins. Infections also increase hepatic lipogenesis. We now have demonstrated that tumor necrosis factor-alpha stimulates lipid synthesis in vivo. 2 h after administration of tumor necrosis factor (25 ,ug/200 g), plasma triglycerides increase 2.2-fold and remain elevated for 17 h. Plasma cholesterol also inc1eases, but this effect appears after 7 h. Tumor necrosis factor rapidly stimulates incorporation of tritiated water into fatty acids in the liver (1-2 h), which persists for 17 h. Also, tumor necrosis factor stimulates hepatic sterol synthesis. Of note, tumor necrosis factor treatment does not stimulate lipid synthesis in other tissuess including adipose tissue. Labeled fatty acids rapidly increase in the plasma, raising the possibility that stimulation of hepatic ipogenesis by tumor necrosis factor contributes to the hyperlipidemia of infection.
Introduction
Infection by microorganisms elicits a complex host response that results in the killing and removal ofthe infectious agents as well as providing immunity against future challenges. This response involves multiple cell types and is modulated by cytokines (1) (2) (3) . The observation that serum from animals treated with endotoxin contained proteins that caused the hemorrhagic necrosis of tumors led to the discovery of tumor necrosis factor (TNF),' a cytokine produced by stimulated macrophages which has been shown to be toxic to a variety of malignant cells (4, 5) .
Disturbances in intermediary metabolism may also occur with infection (6) . Hyperlipidemia, primarily due to the accumulation of very low density lipoprotein (VLDL), is one such metabolic aberration (7, 8) . Studies have shown that in infectious diseases there is both a decrease in the metabolism ofcirculating lipoproteins (9) and an increase in hepatic lipid synthesis (10) . Cerami and co-workers have demonstrated that endotoxinstimulated mouse macrophages secrete a factor, which they called cachectin, that decreases the synthesis and storage of lipid in cultured fat cells (11, 12) . After purification cachectin was shown to be identical to mouse TNF by amino acid sequence analysis (13). This cytokine decreases the activity of adipose tissue lipoprotein lipase, an effect that is due to the decreased synthesis ofthe enzyme (12) . A decrease in lipoprotein lipase activity could lead to a decrtased clearance from the circulation of triglyceriderich lipoproteins, such as VLDL, and thereby result in hyperlipidemia. Thus, the hyperlipidemia that accompanies infection could be mediated by the TNF inhibition of adipose tissue lipoprotein lipase activity. Whether TNF has additional effects that also contribute to the hyperlipidemia is unknown.
Despite the considerable data on the effect of TNF on cultured adipose cells, the effect of TNF on lipid metabolism in other tissues has not been studied. In particular, the effect of TNF on lipid synthesis in the liver, the key organ in the regulation of total body lipid metabolism, has not been examined. We demonstrate that the administration of TNF to intact animals stimulates hepatic lipid synthesis.
Methods
Materials. 3H20 ( (1:5) and the bands corresponding to standards of cholesterol, lanosterol, and squalene were cut from the plate and counted by liquid scintillation. The total nonsaponifidble lipid is the sum of the cholesterol, lanosterol, and squalene bands. The window settings of the scintillation counter were adjusted so that < 0.2% of the tritium counts were recorded in the '4C-window and -10% of the '4C counts, in the tritium window. Calculations were corrected for the spillover of tritium and for`4C, background, and recovery of the internal standard.
The fatty acids were extracted three times with petroleum ether after acidifying the saponified material to pH < 2.0 with concentrated hydrochloric acid. The petroleum ether extract was dried, dissolved in chloroform, and an aliquot counted as described above. The specific activity of the tritiated water was determined individually for each animal by measuring the disintegrations per minute per milliliter of plasma at the end of the experiment and dividing by millimoles of water per milliliter plasma (52 mmol/ml plasma, assuming that plasma is 93% water). The validity of our methodology for measuring lipid synthesis has been demonstrated in earlier publications (14, 15 
Results
Effect of TNF on plasma and liver lipids. The effect of the intravenous administration of TNF 17 h before study on body and liver weight and plasma and liver lipids is shown in Table  I . Hepatic weight was increased 21% in the animals treated with TNF (control 7.57±0.13 g vs. TNF 9.18±0.20 g, P < 0.001), but total body weight was unaffected. Additionally, small intestine and skin weight (data not shown) were also not altered by the administration of TNF. Plasma triglyceride concentrations were increased 67% and the plasma cholesterol levels, 29% in the animals treated with TNF. Hepatic triglyceride content was increased in the TNF-treated animals but this observation is of borderline statistical significance because of the greater degree of variability in the triglyceride concentration in the animals administered TNF. Free-cholesterol content in the liver was unaffected by TNF administration, but hepatic cholesterol ester content was significantly decreased (control 0.84±0.12 mg/g vs. TNF 0.38±0.05 mg/g, P < 0.01). Effect of TNF on lipogenesis in vivo. The effect of TNF administration 16-17 h before measurement of the in vivo incorporation of 3H20 into lipids in a variety of tissues is shown in Table II . As shown in Table II and Fig. 1 , the incorporation of 3H20 into fatty acids, cholesterol, and total nonsaponifiable lipids was increased in the livers of animals treated with TNF. Cholesterol synthesis was increased 2.3-fold, total nonsaponifiable lipid synthesis, 2.2-fold, and fatty acid synthesis, 35% in the TNF-treated animals. It should be recognized that the data presented are on a per gram basis. From the point of view of total body lipid homeostasis, total organ synthesis may be of greater significance. Because, as shown in Table I , liver mass was increased after TNF administration, the increase in fatty acid, cholesterol, and total nonsaponifiable synthesis in the TNFtreated animals was even more marked in the liver when expressed on a per organ basis (fatty acids: control 13.0±0.86 ,mol vs. TNF 21.8±1. 40 Mmol incorporated/h per total organ, 67% increase, P < 0.001; cholesterol: control 8.3±1.9 smol incorporated/h per total organ vs. TNF 23.7±3. 5 Amol incorporated/ h per total organ, 2.9-fold increase, P < 0.01; total nonsaponifiable lipids: control 11.0±2.6 vs. TNF 28.3±4.7 umol incorporated/h per total organ, 2.6-fold increase P < 0.01). Fatty Acids Cholesterol Nonsaponifiable Lipids Figure 1 . Lipid synthesis in the liver. Values are mean±SE. 16 h after the intravenous administration of TNF or saline the animals were injected with 50 mCi i.p. of tritiated water. 1 h later the animals were killed and the liver was removed, weighed, and saponified in a KOHethanol solution. The incorporation of tritiated water into cholesterol (P < 0.001), nonsaponifiable lipids (P < 0.02), and fatty acids (P < 0.02) were determined after petroleum ether extraction. Note, the quantity of labeled cholesterol and total nonsaponifiable lipids in the serum of animals administered TNF was significantly increased (Table II, cholesterol 4 .4-fold, total nonsaponifiable lipids 3.8-fold). This and other laboratories have shown that in short-term 3H20 labeling studies the quantity of labeled sterols in the serum is reflective of hepatic synthesis (16, 17) . Thus, the increase in labeled sterols in the serum reflected the increase in hepatic sterol synthesis. The quantity of labeled fatty acids in the serum was not significantly increased in the TNF-treated animals.
In contrast to the increase in hepatic lipogenesis observed in the TNF-treated animals, the administration of TNF did not stimulate fatty acid, cholesterol, or total nonsaponifiable lipids synthesis in the small intestine, adipose tissue, muscle, or skin (Table II ). These results demonstrate that the ability of TNF to stimulate hepatic fatty acid, cholesterol, and total nonsaponifiable lipid synthesis was an effect specifically localized to the liver.
Effect of TNF on in vitro lipogenesis in the liver. The incorporation of acetate into fatty acid, cholesterol, and total nonsaponifiable lipids was measured in liver slices from control and TNF-treated animals (Table III) . Fatty acid synthesis was increased 97%; cholesterol synthesis, 95%; and total nonsaponifiable lipid synthesis, 74% in the liver slices prepared from animals administered TNF. In contrast, the metabolism ofacetate to CO2 was unaffected in the TNF-treated animals. These results agree with our in vivo observations using 3H20, and further demonstrate that TNF administration stimulates hepatic lipogenesis.
To localize the site at which TNF increased sterologenesis we measured the incorporation of mevalonate into cholesterol, total nonsaponifiable lipids, and CO2 (via the shunt pathway) in liver slices (Table III) . In contrast to our observations using acetate and tritiated water, the incorporation ofmevalonate into cholesterol and total nonsaponifiable lipids was not increased in liver slices prepared from animals treated with TNF. This suggests that the stimulation of sterol synthesis in animals treated with TNF was localized to the early steps ofsterol synthesis (i.e., 186 K R. Feingold and C. Grunfeld Fig. 2 . It is well recognized that HMG CoA reductase activity is modulated by a reversible phosphorylation-dephosphorylation with the phosphorylated form of the enzyme being inactive and the dephosphorylated form, active (18, 19) . During the routine isolation of liver microsomes dephosphorylation (activation) of HMG CoA reductase occurs, and therefore HMG CoA reductase assay performed on these samples represents an index of the total quantity of enzyme present in the tissue. If, however, microsomes are isolated in the presence of fluoride ion, which blocks dephosphorylation, assays of HMG CoA reductase activity are indicative of the quantity of dephosphorylated (active) enzyme in situ. As illustrated in Fig. 2 A, HMG CoA reductase activity in hepatic microsomes isolated in sodium chloride buffer, which does not block dephosphorylation, was increased 72% in the animals treated with TNF. Similarly, as shown in Fig. 2 Time course of TNF effects. As shown in Table IV , at 2, 4, and 7 h after the administration ofTNF there was no difference in either total body or hepatic weight between the control and TNF-treated animals. Plasma triglyceride levels were significantly increased in the TNF-treated animals at all time periods studied. In contrast TNF administration increased plasma cholesterol levels only after 7 h of treatment. Thus, the increase in plasma triglyceride concentration occurred rapidly after the administration of TNF, whereas the increase in plasma cholesterol concentrations required a longer incubation.
The incorporation of 3H20 into hepatic fatty acids was significantly increased in the TNF-treated animals at 1-2, 3-4, and 6-7 h after TNF administration (61, 69, and 48%, respectively). In these experiments 25 Mg of TNF was administered to each animal. An increased incorporation of 3H20 into hepatic fatty acids at 1-2 h was also observed in animals treated with 5 Mg of TNF (control n = 4, 2.67±0.21 gjmol vs. TNF n = 5, 4.83±0.39
Mmol 3H20 incorporated into fatty acids/h per g, P < 0.01). In contrast, the administration of 1 Mg TNF had no effect on hepatic lipid synthesis (control n = 5, 4.81±0.37 ,imol vs. TNF n = 5, 5.19±0.40 ,umol 3H20 incorporated into fatty acids/h per g, NS).
There was a tendency for sterol synthesis to also be increased at these time periods, but the increases did not reach statistical significance (3-4 h, borderline significance P < 0.1). In comparison with our 16-17-h experiments described above, the increase in hepatic fatty acid synthesis was greater at these early time periods, whereas the TNF-induced stimulation in sterol synthesis was more pronounced at the later time. Note, at 1-2 h the quantity of labeled fatty acids in the serum was greatly increased in the TNF-treated animals (control 0.48±0.08 gmol vs. TNF 1.50±0.40 /mol 3H20 incorporated/h per ml serum, P < 0.05), whereas the quantity of labeled cholesterol or nonsaponifiable lipids was no different.
The incorporation of acetate into fatty acids, cholesterol, and total nonsaponifiable lipids were measured in liver slices from control and animals administered TNF 90 mmn before study (Table V) . In agreement with our in vivo studies, fatty acid synthesis was increased 62% in the TNF-treated animals. Sterol synthesis was also increased, but once again this increase was of only borderline statistical significance. Note, the oxidation of acetate to CO2 was decreased 2 h after TNF administration.
Discussion
Infectious diseases frequently result in systemic metabolic changes such as hyperlipidemia (6) (7) (8) (12) . Thus, they postulated that during infections, pro- duction of the cytokine TNF by stimulated macrophages could decrease the clearance ofcirculating lipoprotein and thereby lead to hyperlipidemia (20, 21) . In addition to decreasing lipoprotein lipase activity, TNF has also been shown to inhibit the synthesis of fatty acids in cultured adipocytes by decreasing the activity ofacetyl CoA carboxylase and fatty acid synthetase, the key regulatory enzymes involved in fatty acid synthesis (11, 12, 23) . The decrease in activity of these lipogenic enzymes is due to an inhibition of their synthesis, as has also been observed with lipoprotein lipase. In contrast to the inhibition of the enzymes involved in the accumulation of fat, TNF has been shown to increase lipolysis in 3T3-LI adipocytes by increasing the activity ofhormone sensitive lipase (20, 23) . Thus, TNF both inhibits anabolic lipogenic pathways and stimulates catabolic lipid pathways in adipocytes. It has therefore been proposed that TNF may be responsible for the cachexia and wasting associated with certain systemic infec- (23) .
Despite the considerable information known on the effect of TNF on adipose tissue, the effect of this cytokine on lipid metabolism in other tissues has not been studied. Acute infections in addition to affecting the catabolism of circulating lipoproteins have also been shown to increase hepatic lipogenesis (6) (7) (8) (9) (10) . Whether TNF also mediates this central effect was previously unknown. In this study we have for the first time determined the effect of administering recombinant DNA-produced human TNF on lipid metabolism in vivo in rats. After the administration of TNF, plasma triglyceride levels increased very rapidly. 2 h after TNF treatment, plasma triglyceride concentrations were increased 2.2-fold and remained elevated for at least 17 h (1.7-fold increase). Plasma cholesterol levels also increased in response to TNF administration. At 17 h plasma cholesterol levels in the TNF-treated animals were increased 1.3-fold (P < 0.001). Note, the increase in plasma cholesterol levels was first observed at 7 h (1.3-fold) after TNF administration and was not observed at earlier time periods (2 and 4 h). Thus, TNF administration increased both plasma triglyceride and cholesterol levels, but the increase in triglycerides was considerably greater and occurred more rapidly. Studies are in progress to define the lipoprotein distribution ofcholesterol and triglycerides in animals administered TNF.
The present study also demonstrates that TNF administration stimulated lipid synthesis in the liver. The incorporation of tritiated water into fatty acids in the liver in vivo was increased 1.6-fold at 1-2 h, 1.7-fold at 3-4 h, 1.5-fold at 6-7 h, and 1.3-fold at 16-17 h. Furthermore liver slices from animals treated in vivo with TNF also showed increased fatty acid synthesis. The in vitro incorporation of acetate into fatty acids was increased 1.6-fold at 1.5 h and 2.0-fold at 16 h. Thus, TNF administration rapidly stimulated hepatic fatty acid synthesis, and this effect persisted for an extended period of time. Note, in other tissues such as the small intestine, adipose tissue, and muscle, TNF administration did not significantly affect fatty acid synthesis. Although we and others have found that TNF decreases fatty acid synthesis in cultured adipose cells (11, 20, 23) , we have not demonstrated a decrease in adipose tissue lipogenesis when rats are treated in vivo under conditions that do lead to increased serum triglycerides.
In addition to the stimulation ofhepatic fatty acid synthesis, TNF also enhanced hepatic sterol synthesis. 16-17 h after TNF administration, the incorporation of tritiated water into cholesterol and nonsaponifiable lipids in the liver was increased 2.3-fold and 2.2-fold, respectively. In liver slices obtained 16 h after TNF treatment, the incorporation of acetate into sterols was also increased. In contrast to the effects on hepatic fatty acid synthesis, sterol synthesis was not markedly stimulated soon after TNF treatment. In our 1-2, 3-4, and 6-7 h experiments, we were unable to demonstrate a statistically significant increase in the incorporation of tritiated water into sterols. As we found with fatty acid synthesis, stimulation of sterologenesis by TNF was specifically localized to the liver. No increase in sterol synthesis was seen in the small intestine, adipose tissue, muscle, or skin of TNF-treated animals. Thus, while TNF administration specifically stimulated hepatic sterologenesis, this occurred after an extended period of time as compared with the stimulation of fatty acid synthesis.
Our studies have further shown that the increase in hepatic sterologenesis after TNF administration was localized to the early steps of sterol biosynthesis. The incorporation of mevalonate into cholesterol and nonsaponifiable lipids was not increased in the livers of TNF-treated animals. In contrast, the activity of HMG CoA reductase, the key regulatory enzyme in the cholesterol biosynthetic pathway, was increased after TNF administration. We observed an increase in HMG CoA reductase activity in hepatic microsomes isolated in both sodium chloride (72% increase) or sodium fluoride buffer (58% increase). HMG CoA reductase is inactivated by phosphorylation and activated by dephosphorylation (18, 19) . During the isolation of liver microsomes in sodium chloride buffer, activation of HMG CoA reductase occurred and therefore reductase assays performed in these samples represented an index of the total quantity of enzyme present in the tissue. Isolation of microsomes in sodium fluoride buffers blocked dephosphorylation, and assay ofreductase is indicative of the quantity of active enzyme present in the tissue. The finding that HMG CoA reductase activity was increased to a similar extent in microsomes isolated in either a sodium chloride or sodium fluoride buffer after TNF administration suggests that the increase in activity was due to an increased quantity of enzyme present and not to a change in the phosphorylation state.
Whereas the hyperlipidemia that occurrs in infectious disease has been attributed to an inhibition ofadipose tissue lipoprotein lipase caused by the release ofTNF by stimulated macrophages, the findings of the present study suggest TNF stimulation of hepatic lipid synthesis may also play a role. In support of this is our observation that 1-2 h after TNF administration the increase in hepatic fatty acid synthesis was accompanied by a 3.1-fold increase in the quantity of labeled fatty acids in the serum. Similarly, when hepatic sterol synthesis was maximally increased (16-17 hours), we also observed an increase in the quantity of labeled cholesterol and nonsaponifiable lipids in the serum of the TNF-treated animals after 1 h ofincorporation oflabel (cholesterol, 4.4-fold increase; nonsaponifiable lipids, 3.8-fold increase). Thus, the present study raises the possibility that in addition to decreasing circulating lipoprotein metabolism, TNF also stimulates the production oflipoproteins by the liver, which may contribute to the hyperlipidemia observed in association with infectious diseases. It should be recognized that the mechanism by which TNF increases hepatic lipid synthesis has not been elucidated by the present study. Whether TNF acts directly on hepatocytes or via inducing the release of other cytokines is unknown. Recent studies have demonstrated that TNF stimulates the production of interleukin 1 (24, 25) . We have shown that a variety of cytokines can inhibit adipose tissue lipid metabolism (23) and it is possible that these other cytokines will also affect hepatic lipid synthesis.
In conclusion, our studies demonstrate that the in vivo administration of purified recombinant DNA-produced human TNF can lead to an increase in plasma triglycerides and cholesterol concentrations. Moreover, our studies are the first to demonstrate that TNF stimulates hepatic lipid synthesis. Together with the changes described by others in adipose tissue these effects may represent a coordinate metabolic response to infection. How these alterations in lipid metabolism contribute to the body's host defenses remains to be explored.
